In a mouse model of colitis, researchers found that ERα deletion in CD4+ T cells led to decreased colitis severity, accompanied by fewer IFNy+ and interleukin (IL)‐17A+ proinflammatory CD4+ T cells and increased CD4+ T regulatory cells [24]. The gene discussed is CD4; the disease is colitis.